{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:23:26Z","timestamp":1787801006494,"version":"build-2784847793"},"reference-count":128,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2015,7,3]]},"DOI":"10.1586\/1744666x.2015.1047345","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T09:02:21Z","timestamp":1431594141000},"page":"859-870","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":38,"title":["The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics"],"prefix":"10.1586","volume":"11","author":[{"given":"Mahdi","family":"Alahgholi-Hajibehzad","sequence":"first","affiliation":[{"name":"Department of Immunology, Institute of Experimental Medicine (DETAE), Istanbul University,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Kasapoglu","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute of Experimental Medicine (DETAE), Istanbul University,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Jafari","sequence":"additional","affiliation":[{"name":"Research Center for Immunology, Tabriz University of Medical Science,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Research Center for Immunodeficiencies, Children\u2019s Medical Center, Tehran University of Medical Science,","place":["Iran"]},{"name":"Department of Immunology, School of Medicine, Molecular Immunology Research Center, Tehran University of Medical Science,","place":["Iran"]},{"name":"Universal Scientific Education and Research Network (USERN),","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e328357a829"},{"issue":"1","key":"e_1_3_4_6_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2010.03.016","article-title":"Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients","volume":"225","author":"Masuda M","year":"2010","unstructured":"Masuda M, Matsumoto M, Tanaka S, et al. Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients. J Neuroimmunol 2010;225(1-2):123-31","journal-title":"J Neuroimmunol"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-030409-101212"},{"issue":"6","key":"e_1_3_4_8_1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.it.2009.03.008","article-title":"New insights into the regulation of human B-cell differentiation","volume":"30","author":"Schmidlin H","year":"2009","unstructured":"Schmidlin H, Diehl SA, Blom B. New insights into the regulation of human B-cell differentiation. Trends Immunol 2009;30(6):277-85","journal-title":"Trends Immunol"},{"issue":"9","key":"e_1_3_4_9_1","doi-asserted-by":"crossref","first-page":"991","DOI":"10.15252\/embr.201338233","article-title":"Regulatory T cells suppress CD4+ T cells through NFAT-dependent transcriptional mechanisms","volume":"15","author":"Shin DS","year":"2014","unstructured":"Shin DS, Jordan A, Basu S, et al. Regulatory T cells suppress CD4+ T cells through NFAT-dependent transcriptional mechanisms. EMBO Rep 2014;15(9):991-9","journal-title":"EMBO Rep"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.7.4180"},{"issue":"2","key":"e_1_3_4_11_1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.expneurol.2009.09.022","article-title":"T-bet deficiency decreases susceptibility to experimental myasthenia gravis","volume":"220","author":"Liu R","year":"2009","unstructured":"Liu R, Hao J, Dayao CS, et al. T-bet deficiency decreases susceptibility to experimental myasthenia gravis. Exp Neurol 2009;220(2):366-73","journal-title":"Exp Neurol"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.12.015"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.12.011"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2012.09.012"},{"issue":"2","key":"e_1_3_4_15_1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4049\/jimmunol.0802046","article-title":"Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients","volume":"183","author":"Luther C","year":"2009","unstructured":"Luther C, Adamopoulou E, Stoeckle C, et al. Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients. J Immunol 2009;183(2):841-8","journal-title":"J Immunol"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3900"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70063-8"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e32833cc968"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.03.003"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e328364d6cd"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e3283572588"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22312"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.03.007"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2013.08.271"},{"issue":"4","key":"e_1_3_4_25_1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/jamaneurol.2014.4103","article-title":"A Genome-wide Association Study of Myasthenia Gravis","volume":"72","author":"Renton AE","year":"2015","unstructured":"Renton AE, Pliner HA, Provenzano C, et al. A Genome-wide Association Study of Myasthenia Gravis. JAMA Neurol 2015;72(4):396-404","journal-title":"JAMA Neurol"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916930903555935"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.03.001"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6478-6"},{"issue":"2","key":"e_1_3_4_29_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1468-1331.2012.03850.x","article-title":"Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009","volume":"20","author":"Pedersen EG","year":"2013","unstructured":"Pedersen EG, Hallas J, Hansen K, et al. Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009. Eur J Neurol 2013;20(2):309-14","journal-title":"Eur J Neurol"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916930903518073"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.2393"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.07.012"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2011.01008.x"},{"key":"e_1_3_4_34_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jneuroim.2008.05.020","article-title":"Reflections on the \u201cintrathymic pathogenesis\u201d of myasthenia gravis","volume":"201","author":"Hohlfeld R","year":"2008","unstructured":"Hohlfeld R, Wekerle H. Reflections on the \u201cintrathymic pathogenesis\u201d of myasthenia gravis. J Neuroimmunol 2008;201-202:21-7","journal-title":"J Neuroimmunol"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0b013e31828a0090"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916930903563491"},{"issue":"10","key":"e_1_3_4_37_1","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1097\/JTO.0b013e3181f1f63f","article-title":"The autoimmune regulator AIRE in thymoma biology: autoimmunity and beyond","volume":"5","author":"Marx A","year":"2010","unstructured":"Marx A, Hohenberger P, Hoffmann H, et al. The autoimmune regulator AIRE in thymoma biology: autoimmunity and beyond. J Thorac Oncol 2010;5(10 Suppl 4):S266-72","journal-title":"J Thorac Oncol"},{"issue":"3","key":"e_1_3_4_38_1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2249.2007.03442.x","article-title":"Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas","volume":"149","author":"Scarpino S","year":"2007","unstructured":"Scarpino S, Di Napoli A, Stoppacciaro A, et al. Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas. Clin Exp Immunol 2007;149(3):504-12","journal-title":"Clin Exp Immunol"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2012.05.006"},{"issue":"4","key":"e_1_3_4_40_1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.21628","article-title":"CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia","volume":"66","author":"Berrih-Aknin S","year":"2009","unstructured":"Berrih-Aknin S, Ruhlmann N, Bismuth J, et al. CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia. Ann Neurol 2009;66(4):521-31","journal-title":"Ann Neurol"},{"issue":"8","key":"e_1_3_4_41_1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.neurol.2013.02.005","article-title":"The thymus in autoimmune Myasthenia Gravis: Paradigm for a tertiary lymphoid organ","volume":"169","author":"Weiss JM","year":"2013","unstructured":"Weiss JM, Cufi P, Le Panse R, et al. The thymus in autoimmune Myasthenia Gravis: Paradigm for a tertiary lymphoid organ. Rev Neurol (Paris) 2013;169(8-9):640-9","journal-title":"Rev Neurol (Paris)"},{"key":"e_1_3_4_42_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.2012.06791.x","article-title":"Defects of immunoregulatory mechanisms in myasthenia gravis: role of IL-17","volume":"1274","author":"Gradolatto A","year":"2012","unstructured":"Gradolatto A, Nazzal D, Foti M, et al. Defects of immunoregulatory mechanisms in myasthenia gravis: role of IL-17. Ann N Y Acad Sci 2012;1274:40-7","journal-title":"Ann N Y Acad Sci"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00152"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjt026"},{"issue":"12","key":"e_1_3_4_45_1","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.4049\/jimmunol.0903109","article-title":"Control of T cell reactivation by regulatory Qa-1-restricted CD8+ T cells","volume":"184","author":"Varthaman A","year":"2010","unstructured":"Varthaman A, Khallou-Laschet J, Clement M, et al. Control of T cell reactivation by regulatory Qa-1-restricted CD8+ T cells. J Immunol 2010;184(12):6585-91","journal-title":"J Immunol"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141623"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2849"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05129.x"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.11-193672"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-012-9496-8"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2014.12.001"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12428"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-7-89"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-069229"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0904028"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024226"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00030"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2011.01017.x"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7219"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0049"},{"issue":"1","key":"e_1_3_4_61_1","doi-asserted-by":"crossref","first-page":"e86551","DOI":"10.1371\/journal.pone.0086551","article-title":"Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation","volume":"9","author":"Sega EI","year":"2014","unstructured":"Sega EI, Leveson-Gower DB, Florek M, et al. Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation. PLoS One 2014;9(1):e86551","journal-title":"PLoS One"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102045"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1424792112"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001628"},{"key":"e_1_3_4_65_1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fimmu.2012.00268","article-title":"Competition for IL-2 between Regulatory and Effector T Cells to Chisel Immune Responses","volume":"3","author":"Hofer T","year":"2012","unstructured":"Hofer T, Krichevsky O, Altan-Bonnet G. Competition for IL-2 between Regulatory and Effector T Cells to Chisel Immune Responses. Front Immunol 2012;3:268","journal-title":"Front Immunol"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.06.003"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2012.06844.x"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.03.009"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.4.2132"},{"issue":"9","key":"e_1_3_4_70_1","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.4049\/jimmunol.0903183","article-title":"Naturally occurring CD4+CD25+ regulatory T cells prevent but do not improve experimental myasthenia gravis","volume":"185","author":"Nessi V","year":"2010","unstructured":"Nessi V, Nava S, Ruocco C, et al. Naturally occurring CD4+CD25+ regulatory T cells prevent but do not improve experimental myasthenia gravis. J Immunol 2010;185(9):5656-67","journal-title":"J Immunol"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203224"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2013.06.007"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12116"},{"issue":"4","key":"e_1_3_4_74_1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.0300-9475.2004.01410.x","article-title":"Circulating CD4+CD25+ and CD4+CD25+ T cells in myasthenia gravis and in relation to thymectomy","volume":"59","author":"Huang YM","year":"2004","unstructured":"Huang YM, Pirskanen R, Giscombe R, et al. Circulating CD4+CD25+ and CD4+CD25+ T cells in myasthenia gravis and in relation to thymectomy. Scand J Immunol 2004;59(4):408-14","journal-title":"Scand J Immunol"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2004.04.005"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2005.02220.x"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.10.001"},{"issue":"5","key":"e_1_3_4_78_1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10875-012-9685-0","article-title":"Changes of Treg-associated molecules on CD4+CD25 +Treg cells in myasthenia gravis and effects of immunosuppressants","volume":"32","author":"Xu WH","year":"2012","unstructured":"Xu WH, Zhang AM, Ren MS, et al. Changes of Treg-associated molecules on CD4+CD25 +Treg cells in myasthenia gravis and effects of immunosuppressants. J Clin Immunol 2012;32(5):975-83","journal-title":"J Clin Immunol"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2005.03.011"},{"issue":"1","key":"e_1_3_4_80_1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2008.11.015","article-title":"The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis","volume":"122","author":"Zhang Y","year":"2009","unstructured":"Zhang Y, Wang HB, Chi LJ, et al. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis. Immunol Lett 2009;122(1):52-7","journal-title":"Immunol Lett"},{"key":"e_1_3_4_81_1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neulet.2012.11.048","article-title":"FOXP3 -3279 and IVS9+459 polymorphisms are associated with genetic susceptibility to myasthenia gravis","volume":"534","author":"Zhang J","year":"2013","unstructured":"Zhang J, Chen Y, Jia G, et al. FOXP3 -3279 and IVS9+459 polymorphisms are associated with genetic susceptibility to myasthenia gravis. Neurosci Lett 2013;534:274-8","journal-title":"Neurosci Lett"},{"key":"e_1_3_4_82_1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fimmu.2013.00326","article-title":"The many faces of AIRE in central tolerance","volume":"4","author":"Laan M","year":"2013","unstructured":"Laan M, Peterson P. The many faces of AIRE in central tolerance. Front Immunol 2013;4:326","journal-title":"Front Immunol"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141532"},{"issue":"6","key":"e_1_3_4_84_1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-3083.2010.02397.x","article-title":"Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I","volume":"71","author":"Wolff AS","year":"2010","unstructured":"Wolff AS, Oftedal BE, Kisand K, et al. Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. Scand J Immunol 2010;71(6):459-67","journal-title":"Scand J Immunol"},{"issue":"4","key":"e_1_3_4_85_1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jaut.2010.07.008","article-title":"Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3(+) precursors and impaired activated population","volume":"35","author":"Laakso SM","year":"2010","unstructured":"Laakso SM, Laurinolli TT, Rossi LH, et al. Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3(+) precursors and impaired activated population. J Autoimmun 2010;35(4):351-7","journal-title":"J Autoimmun"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2010.09.007"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1004112"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjr039"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.540"},{"issue":"4","key":"e_1_3_4_90_1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3324\/haematol.2012.076430","article-title":"Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease","volume":"98","author":"Chakraborty R","year":"2013","unstructured":"Chakraborty R, Mahendravada A, Perna SK, et al. Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease. Haematologica 2013;98(4):533-7","journal-title":"Haematologica"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1168"},{"issue":"11","key":"e_1_3_4_92_1","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.4049\/jimmunol.1202298","article-title":"OX40L\/Jagged1 cosignaling by GM-CSF-induced bone marrow-derived dendritic cells is required for the expansion of functional regulatory T cells","volume":"190","author":"Gopisetty A","year":"2013","unstructured":"Gopisetty A, Bhattacharya P, Haddad C, et al. OX40L\/Jagged1 cosignaling by GM-CSF-induced bone marrow-derived dendritic cells is required for the expansion of functional regulatory T cells. J Immunol 2013;190(11):5516-25","journal-title":"J Immunol"},{"issue":"3","key":"e_1_3_4_93_1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/intimm\/dxn147","article-title":"GM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis","volume":"21","author":"Ganesh BB","year":"2009","unstructured":"Ganesh BB, Cheatem DM, Sheng JR, et al. GM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis. Int Immunol 2009;21(3):269-82","journal-title":"Int Immunol"},{"issue":"2","key":"e_1_3_4_94_1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1189\/jlb.0310154","article-title":"GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms","volume":"89","author":"Bhattacharya P","year":"2011","unstructured":"Bhattacharya P, Gopisetty A, Ganesh BB, et al. GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms. J Leukoc Biol 2011;89(2):235-49","journal-title":"J Leukoc Biol"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S1355"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.03.509"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2011.10.010"},{"issue":"3","key":"e_1_3_4_98_1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/mus.23488","article-title":"Granulocyte macrophage colony-stimulating factor treatment of a patient in myasthenic crisis: effects on regulatory T cells","volume":"46","author":"Rowin J","year":"2012","unstructured":"Rowin J, Thiruppathi M, Arhebamen E, et al. Granulocyte macrophage colony-stimulating factor treatment of a patient in myasthenic crisis: effects on regulatory T cells. Muscle Nerve 2012;46(3):449-53","journal-title":"Muscle Nerve"},{"key":"e_1_3_4_99_1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1749-6632.2012.06840.x","article-title":"Functional defect in regulatory T cells in myasthenia gravis","volume":"1274","author":"Thiruppathi M","year":"2012","unstructured":"Thiruppathi M, Rowin J, Li Jiang Q, et al. Functional defect in regulatory T cells in myasthenia gravis. Ann N Y Acad Sci 2012;1274:68-76","journal-title":"Ann N Y Acad Sci"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071119"},{"issue":"1","key":"e_1_3_4_101_1","first-page":"S8","article-title":"The role of GM-CSF in multiple sclerosis","volume":"63","author":"Schottelius A","year":"2013","unstructured":"Schottelius A. The role of GM-CSF in multiple sclerosis. Drug Res (Stuttg) 2013;63(Suppl 1):S8","journal-title":"Drug Res (Stuttg)"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202450"},{"key":"e_1_3_4_103_1","article-title":"MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib\/IIa randomised, double-blind, placebo-controlled, dose-escalation trial","author":"Behrens F","year":"2014","unstructured":"Behrens F, Tak PP, Ostergaard M, et al. MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib\/IIa randomised, double-blind, placebo-controlled, dose-escalation trial. Ann Rheum Dis 2014. [Epub ahead of print]","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2014.896448"},{"key":"e_1_3_4_105_1","doi-asserted-by":"crossref","DOI":"10.1089\/jir.2014.0149","article-title":"Dual role of GM-CSF as a Pro-inflammatory and a regulatory cytokine: implications for immune therapy","author":"Bhattacharya P","year":"2015","unstructured":"Bhattacharya P, Budnick I, Singh M, et al. Dual role of GM-CSF as a Pro-inflammatory and a regulatory cytokine: implications for immune therapy. J Interferon Cytokine Res 2015. [Epub ahead of print]","journal-title":"J Interferon Cytokine Res"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111594"},{"issue":"12","key":"e_1_3_4_107_1","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/j.1468-1331.2012.03773.x","article-title":"Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: a pilot study","volume":"19","author":"Askmark H","year":"2012","unstructured":"Askmark H, Haggard L, Nygren I, et al. Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: a pilot study. Eur J Neurol 2012;19(12):1554-60","journal-title":"Eur J Neurol"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32835cfc16"},{"issue":"10","key":"e_1_3_4_109_1","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/eji.201242370","article-title":"The role of 1alpha,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells","volume":"42","author":"Urry Z","year":"2012","unstructured":"Urry Z, Chambers ES, Xystrakis E, et al. The role of 1alpha,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells. Eur J Immunol 2012;42(10):2697-708","journal-title":"Eur J Immunol"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2015.03.008"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.2.732"},{"issue":"1","key":"e_1_3_4_112_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10072-013-1460-3","article-title":"Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis","volume":"35","author":"Li Y","year":"2014","unstructured":"Li Y, Rauniyar VK, Yin WF, et al. Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis. Neurol Sci 2014;35(1):29-34","journal-title":"Neurol Sci"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2005.01.013"},{"issue":"6","key":"e_1_3_4_114_1","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/mus.21280","article-title":"Myasthenia gravis associated with etanercept therapy","volume":"39","author":"Fee DB","year":"2009","unstructured":"Fee DB, Kasarskis EJ. Myasthenia gravis associated with etanercept therapy. Muscle Nerve 2009;39(6):866-70","journal-title":"Muscle Nerve"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105143"},{"key":"e_1_3_4_116_1","doi-asserted-by":"crossref","first-page":"e1420","DOI":"10.1038\/cddis.2014.377","article-title":"Human thymus medullary epithelial cells promote regulatory T-cell generation by stimulating interleukin-2 production via ICOS ligand","volume":"5","author":"Nazzal D","year":"2014","unstructured":"Nazzal D, Gradolatto A, Truffault F, et al. Human thymus medullary epithelial cells promote regulatory T-cell generation by stimulating interleukin-2 production via ICOS ligand. Cell Death Dis 2014;5:e1420","journal-title":"Cell Death Dis"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1159\/000069079"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300936"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0904055107"},{"issue":"1","key":"e_1_3_4_120_1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.clim.2014.04.008","article-title":"Effects of Lactobacillus rhamnosus on allergic march model by suppressing Th2, Th17, and TSLP responses via CD4(+)CD25(+)Foxp3(+) Tregs","volume":"153","author":"Kim HJ","year":"2014","unstructured":"Kim HJ, Kim YJ, Lee SH, et al. Effects of Lactobacillus rhamnosus on allergic march model by suppressing Th2, Th17, and TSLP responses via CD4(+)CD25(+)Foxp3(+) Tregs. Clin Immunol 2014;153(1):178-86","journal-title":"Clin Immunol"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009009"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.11.050"},{"issue":"2","key":"e_1_3_4_123_1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.imlet.2011.04.005","article-title":"An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells","volume":"138","author":"Hwang I","year":"2011","unstructured":"Hwang I, Ahn G, Park E, et al. An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells. Immunol Lett 2011;138(2):169-78","journal-title":"Immunol Lett"},{"key":"e_1_3_4_124_1","doi-asserted-by":"crossref","first-page":"460610","DOI":"10.1155\/2015\/460610","article-title":"Deficits in endogenous adenosine formation by ecto-5\u2019-nucleotidase\/CD73 impair neuromuscular transmission and immune competence in experimental autoimmune myasthenia gravis","volume":"2015","author":"Oliveira L","year":"2015","unstructured":"Oliveira L, Correia A, Cristina Costa A, et al. Deficits in endogenous adenosine formation by ecto-5\u2019-nucleotidase\/CD73 impair neuromuscular transmission and immune competence in experimental autoimmune myasthenia gravis. Mediators Inflamm 2015;2015:460610","journal-title":"Mediators Inflamm"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-081646"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821ccce4"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711175105"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838437"},{"issue":"5","key":"e_1_3_4_129_1","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/eji.201142088","article-title":"Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity","volume":"42","author":"Li N","year":"2012","unstructured":"Li N, Mu L, Wang J, et al. Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity. Eur J Immunol 2012;42(5):1140-51","journal-title":"Eur J Immunol"},{"issue":"11","key":"e_1_3_4_130_1","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1002\/art.34601","article-title":"Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells","volume":"64","author":"Ju JH","year":"2012","unstructured":"Ju JH, Heo YJ, Cho ML, et al. Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells. Arthritis Rheum 2012;64(11):3543-52","journal-title":"Arthritis Rheum"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.12.004"},{"issue":"1","key":"e_1_3_4_132_1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/eji.200838699","article-title":"CD25+ T(reg) specifically suppress auto-Ab generation against pancreatic tissue autoantigens","volume":"39","author":"Ludwig-Portugall I","year":"2009","unstructured":"Ludwig-Portugall I, Hamilton-Williams EE, Gotot J, et al. CD25+ T(reg) specifically suppress auto-Ab generation against pancreatic tissue autoantigens. Eur J Immunol 2009;39(1):225-33","journal-title":"Eur J Immunol"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/1744666X.2015.1047345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T09:39:45Z","timestamp":1770370785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/1744666X.2015.1047345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":128,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7,3]]}},"alternative-id":["10.1586\/1744666X.2015.1047345"],"URL":"https:\/\/doi.org\/10.1586\/1744666x.2015.1047345","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-05-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}